Amoxapine is an FDA-approved drug belonging to the class of second-generation tricyclic dibenzoxazepine antidepressants. Generally, it is reserved for resistant or persistent depression. The goal of this activity is to familiarize practitioners with the proper usage of this drug and recognize the adverse effects of this medication. This activity also explores the roles of a cohesive interprofessional team in treating patients using amoxapine to treat their depression.

**Objectives:**
- Describe the indications of amoxapine in a patient suffering from depression or anxiety.
- Identify the mechanism of action of amoxapine and its active metabolites.
- Explain the correct methods for monitoring toxicity with amoxapine.
- Summarize the importance of antidepressant stewardship and how it affects refractory depression related to improving care coordination among the interprofessional team when initiating therapy.